Join us on March 31 for a panel discussion on how to bridge data and business process islands between different enterprises, internal applications, and even systems within the same organization. We will share a live demo that highlights how disparate pharmaceutical supply chain operations can be seamlessly connected so every participating entity has real-time insight into their business while preserving privacy for each stakeholder.
Guido Rijo, Vice President, Supply Chain Digital Transformation, Johnson & Johnson
Lakshmi H Shastry, Blockchain Architect, Brillio
Manish Grover, Partners & Industry Solutions, Digital Asset
While significant technological advancements have been made, supply chain processes in the pharmaceuticals industry still operate in islands across participating organizations and across applications within the same enterprise. Using real life examples, we will explore how to reduce latencies and average inventory levels in the end-to-end supply chain so it is more responsive and transparent.
Thus, data and process islands result in significant reconciliation efforts that drive up cost and reduce responsiveness. To ensure real-time transaction visibility across the supply chain, business leaders in pharma must implement a solution that orchestrates and optimizes multiparty business workflows. The demo will combine the use of AI and APIs with smart contracts (Daml) and distributed ledger technology.